Found: 11
Select item for more details and to access through your institution.
Fecal microbiota potentiate checkpoint inhibitors, unleash microbiome startups.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 5, p. 529, doi. 10.1038/d41587-021-00002-w
- By:
- Publication type:
- Article
Big pharma buys into exosomes for drug delivery.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 11, p. 1226, doi. 10.1038/s41587-020-0725-7
- By:
- Publication type:
- Article
Exosome redux.
- Published in:
- Nature Biotechnology, 2019, v. 37, n. 12, p. 1395, doi. 10.1038/s41587-019-0326-5
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 9, p. 1093, doi. 10.1038/nbt0905-1093
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 7, p. 831, doi. 10.1038/nbt0705-831
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 5, p. 559, doi. 10.1038/nbt0505-559
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 12, p. 1531, doi. 10.1038/nbt1204-1531
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 11, p. 1381, doi. 10.1038/nbt1104-1381
- By:
- Publication type:
- Article
RESEARCH HIGHLIGHTS.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 8, p. 967, doi. 10.1038/nbt0804-967
- By:
- Publication type:
- Article
Research Notes.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 6, p. 686, doi. 10.1038/nbt0604-686
- By:
- Publication type:
- Article
Research Notes.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 2, p. 175, doi. 10.1038/nbt0204-175
- By:
- Publication type:
- Article